Profound Medical (PROF)
(Real Time Quote from BATS)
$7.80 USD
0.00 (0.00%)
Updated Sep 23, 2024 10:24 AM ET
3-Hold of 5 3
F Value C Growth C Momentum F VGM
Profound Medical (PROF) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$14.50 | $19.00 | $9.00 | 85.90% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for Profound Medical comes to $14.50. The forecasts range from a low of $9.00 to a high of $19.00. The average price target represents an increase of 85.9% from the last closing price of $7.80.
Analyst Price Targets (4 )
Broker Rating
Profound Medical currently has an average brokerage recommendation (ABR) of 1.40 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 1.40 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, four are Strong Buy, representing 80% of all recommendations. A month ago, Strong Buy represented 80%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.40 | 1.40 | 1.40 | 1.40 | 1.80 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/9/2024 | Raymond James Ltd. | Rahul Sarugaser | Strong Buy | Strong Buy |
8/8/2024 | Not Identified | Not Identified | Hold | Hold |
7/23/2024 | Lake Street Capital Markets | Frank Takkinen | Strong Buy | Strong Buy |
7/15/2024 | Not Identified | Not Identified | Hold | Strong Buy |
3/8/2024 | Leede Jones Gable | Douglas W Loe | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.40 |
ABR (Last week) | 1.40 |
# of Recs in ABR | 5 |
Average Target Price | $14.50 |
LT Growth Rate | NA |
Industry | Medical - Drugs |
Industry Rank by ABR | 84 of 253 |
Current Quarter EPS Est: | -0.31 |
PROF FAQs
Profound Medical (PROF) currently has an average brokerage recommendation (ABR) of 1.40 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 5 brokerage firms.
The average price target for Profound Medical (PROF) is $14.50. The current on short-term price targets is based on 4 reports.
The forecasts for Profound Medical (PROF) range from a low of $9 to a high of $19. The average price target represents a increase of $85.90 from the last closing price of $7.80.
The current UPSIDE for Profound Medical (PROF) is 85.90%
Based on short-term price targets offered by four analysts, the average price target for Profound Medical comes to $14.50. The forecasts range from a low of $9.00 to a high of $19.00. The average price target represents an increase of 85.9% from the last closing price of $7.80.